On December 3, the Drug Enforcement Administration launched Fentanyl Free America, “a comprehensive enforcement initiative and public awareness campaign aimed…
The Food and Drug Administration is reportedly providing guidance and “positive feedback” for a proposed nalmefene product that will last…
“He was awesome,” Alexis Pleus, executive director of Truth Pharm, a small harm reduction organization based in Binghamton, New York,…
The Drug Enforcement Administration has raised aggregate production quotas (APQ) for the active ingredients in Adderall, Ritalin and Concerta, as…
In late September, Representatives Adam Gray (D-CA) and Gabe Evans (R-CO) introduced the “Combatting Fentanyl Poisonings Act of 2025.” It's…
Indivior PLC has discontinued marketing for Opvee, the opioid-overdose reversal product that the pharmaceutical company had claimed was more effective…
Lenacapavir, the new long-acting HIV prevention medication that hit the United States market with a price tag of over $28,000…
The era of direct-to-consumer (DTC) pharmaceutical commercials may be coming to a close. On September 9, President Donald Trump signed…
The Department of Homeland Security (DHS) never created a mandatory data collection program to evaluate whether its fentanyl enforcement operations…
On August 19, United States warships set course for Venezuela. They've been deployed there for the specific purpose of targeting…